Cargando…

Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling

Natural control of HIV-1 is a characteristic of <1% of HIV-1-infected individuals, so called elite controllers (EC). In this study, we sought to identify signaling pathways associated with the EC phenotype using integrative proteo-transcriptomic analysis and immunophenotyping. We found HIF signal...

Descripción completa

Detalles Bibliográficos
Autores principales: Akusjärvi, Sara Svensson, Ambikan, Anoop T., Krishnan, Shuba, Gupta, Soham, Sperk, Maike, Végvári, Ákos, Mikaeloff, Flora, Healy, Katie, Vesterbacka, Jan, Nowak, Piotr, Sönnerborg, Anders, Neogi, Ujjwal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718889/
https://www.ncbi.nlm.nih.gov/pubmed/35005552
http://dx.doi.org/10.1016/j.isci.2021.103607
_version_ 1784624826589118464
author Akusjärvi, Sara Svensson
Ambikan, Anoop T.
Krishnan, Shuba
Gupta, Soham
Sperk, Maike
Végvári, Ákos
Mikaeloff, Flora
Healy, Katie
Vesterbacka, Jan
Nowak, Piotr
Sönnerborg, Anders
Neogi, Ujjwal
author_facet Akusjärvi, Sara Svensson
Ambikan, Anoop T.
Krishnan, Shuba
Gupta, Soham
Sperk, Maike
Végvári, Ákos
Mikaeloff, Flora
Healy, Katie
Vesterbacka, Jan
Nowak, Piotr
Sönnerborg, Anders
Neogi, Ujjwal
author_sort Akusjärvi, Sara Svensson
collection PubMed
description Natural control of HIV-1 is a characteristic of <1% of HIV-1-infected individuals, so called elite controllers (EC). In this study, we sought to identify signaling pathways associated with the EC phenotype using integrative proteo-transcriptomic analysis and immunophenotyping. We found HIF signaling and glycolysis as specific traits of the EC phenotype together with dysregulation of HIF target gene transcription. A higher proportion of HIF-1α and HIF-1β in the nuclei of CD4(+) and CD8(+) T cells in the male EC were observed, indicating a potential increased activation of the HIF signaling pathway. Furthermore, intracellular glucose levels were elevated in EC even as the surface expression of the metabolite transporters Glut1 and MCT-1 were decreased on lymphocytes indicative of unique metabolic uptake and flux profile. Combined, our data show that glycolytic modulation and altered HIF signaling is a unique feature of the male EC phenotype that may contribute to natural control of HIV-1.
format Online
Article
Text
id pubmed-8718889
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87188892022-01-07 Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling Akusjärvi, Sara Svensson Ambikan, Anoop T. Krishnan, Shuba Gupta, Soham Sperk, Maike Végvári, Ákos Mikaeloff, Flora Healy, Katie Vesterbacka, Jan Nowak, Piotr Sönnerborg, Anders Neogi, Ujjwal iScience Article Natural control of HIV-1 is a characteristic of <1% of HIV-1-infected individuals, so called elite controllers (EC). In this study, we sought to identify signaling pathways associated with the EC phenotype using integrative proteo-transcriptomic analysis and immunophenotyping. We found HIF signaling and glycolysis as specific traits of the EC phenotype together with dysregulation of HIF target gene transcription. A higher proportion of HIF-1α and HIF-1β in the nuclei of CD4(+) and CD8(+) T cells in the male EC were observed, indicating a potential increased activation of the HIF signaling pathway. Furthermore, intracellular glucose levels were elevated in EC even as the surface expression of the metabolite transporters Glut1 and MCT-1 were decreased on lymphocytes indicative of unique metabolic uptake and flux profile. Combined, our data show that glycolytic modulation and altered HIF signaling is a unique feature of the male EC phenotype that may contribute to natural control of HIV-1. Elsevier 2021-12-10 /pmc/articles/PMC8718889/ /pubmed/35005552 http://dx.doi.org/10.1016/j.isci.2021.103607 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Akusjärvi, Sara Svensson
Ambikan, Anoop T.
Krishnan, Shuba
Gupta, Soham
Sperk, Maike
Végvári, Ákos
Mikaeloff, Flora
Healy, Katie
Vesterbacka, Jan
Nowak, Piotr
Sönnerborg, Anders
Neogi, Ujjwal
Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
title Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
title_full Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
title_fullStr Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
title_full_unstemmed Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
title_short Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
title_sort integrative proteo-transcriptomic and immunophenotyping signatures of hiv-1 elite control phenotype: a cross-talk between glycolysis and hif signaling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718889/
https://www.ncbi.nlm.nih.gov/pubmed/35005552
http://dx.doi.org/10.1016/j.isci.2021.103607
work_keys_str_mv AT akusjarvisarasvensson integrativeproteotranscriptomicandimmunophenotypingsignaturesofhiv1elitecontrolphenotypeacrosstalkbetweenglycolysisandhifsignaling
AT ambikananoopt integrativeproteotranscriptomicandimmunophenotypingsignaturesofhiv1elitecontrolphenotypeacrosstalkbetweenglycolysisandhifsignaling
AT krishnanshuba integrativeproteotranscriptomicandimmunophenotypingsignaturesofhiv1elitecontrolphenotypeacrosstalkbetweenglycolysisandhifsignaling
AT guptasoham integrativeproteotranscriptomicandimmunophenotypingsignaturesofhiv1elitecontrolphenotypeacrosstalkbetweenglycolysisandhifsignaling
AT sperkmaike integrativeproteotranscriptomicandimmunophenotypingsignaturesofhiv1elitecontrolphenotypeacrosstalkbetweenglycolysisandhifsignaling
AT vegvariakos integrativeproteotranscriptomicandimmunophenotypingsignaturesofhiv1elitecontrolphenotypeacrosstalkbetweenglycolysisandhifsignaling
AT mikaeloffflora integrativeproteotranscriptomicandimmunophenotypingsignaturesofhiv1elitecontrolphenotypeacrosstalkbetweenglycolysisandhifsignaling
AT healykatie integrativeproteotranscriptomicandimmunophenotypingsignaturesofhiv1elitecontrolphenotypeacrosstalkbetweenglycolysisandhifsignaling
AT vesterbackajan integrativeproteotranscriptomicandimmunophenotypingsignaturesofhiv1elitecontrolphenotypeacrosstalkbetweenglycolysisandhifsignaling
AT nowakpiotr integrativeproteotranscriptomicandimmunophenotypingsignaturesofhiv1elitecontrolphenotypeacrosstalkbetweenglycolysisandhifsignaling
AT sonnerborganders integrativeproteotranscriptomicandimmunophenotypingsignaturesofhiv1elitecontrolphenotypeacrosstalkbetweenglycolysisandhifsignaling
AT neogiujjwal integrativeproteotranscriptomicandimmunophenotypingsignaturesofhiv1elitecontrolphenotypeacrosstalkbetweenglycolysisandhifsignaling